期刊文献+

蛋白激酶C活性在脑血管痉挛过程中的变化 被引量:1

PKC activity change in the process of cerebral vasospasm
下载PDF
导出
摘要 目的探讨蛋白激酶C(PKC)活性在脑血管痉挛(CVS)过程中的变化及其意义。方法日本大耳白兔25只,随机分为对照组(5只)与模型组(CVS组,20只),CVS组又分为1、3、5、8 d组,每组5只。采用枕大池2次注血法建立脑血管痉挛动物模型,血管造影观察基底动脉(BA)痉挛,放射免疫法和放射性同位素标记蛋白激酶测定法动态测定血浆内皮素和兔BA管壁PKC活性。结果枕大池2次注血法可以成功构建脑血管痉挛模型,是一种简便、可靠的方法;模型组血浆中内皮素含量和BA壁内PKC的活性均明显升高,且在5 d组达到峰值,与对照组相比差异有统计学意义(P<0.05)。结论PKC活性与CVS的严重程度呈正相关。 Objective To investigate the change of protein kinase C in the process of cerebral vasospasm (CVS) and evaluate its significance. Methods The subjects were divided into control group (n = 5) and CVS group (n : 20). CVS group was divided into day 1, day 3, day 5, and day 8 subgroups. "Twice-hemorrhage" method was used to establish the rabbit model, angiography was performed to observe the cerebral vasospasm of the basilar artery, and ET level and PKC activity were measured with radioimmunoassay and radioisotopic protein kinase assay kit. Results The "twice-hemorrhage" rabbit model was a simple and reliable one. ET level in the blood plasma and PKC activity of the basilar artery vessel wall was increased in the CVS group, and reached peak in the day 5 group. The difference was significant (P〈0.05) compared with that in the control group. Conclusion There is a positive correlation between PKC activity and CVS severity.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2007年第5期575-577,共3页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 陕西省科技攻关基金资助项目(No.2002K-G6)
关键词 脑血管痉挛 蛋白激酶C 内皮素 cerebral vasospasm (CVS) protein kinase C (PKC) endothelin (ET)
  • 相关文献

参考文献8

  • 1Nishizawa S,Laher I.Signaling mechanisms in cerebral vasospasm[J].TCM,2005,15(1):24-27.
  • 2Lin CL,Jeng AY,Howng SL,et al.Endothelin and subarachnoid hemorrhage-induced cerebral vasospasm:pathogenesis and treatment[J].Curr Med Chem,2004,11:1779-1791.
  • 3Laher I,Zhang JH.Protein kinase C and cerebral vasospasm[J].J Cereb Blood Flow Metab,2001,21:887-906.
  • 4Nishizawa S,Yamamoto S,Yokoyama T,et al.Dysfunction of nitric oxidesynthase induces protein kinase C activation resulting in vasospasm after subarachnoid hemorrhage[J].Neurol Res,1997,19:558-562.
  • 5Nishizawa S,Obara K,Koide M,et al.Attenuation of canine cerebral vasospasm after subarachnoid hemorrhage by protein kinase C inhibitors despite augmented phosphorylation of myosin light chain[J].J Vasc Res,2003,40:169-178.
  • 6Masayo K,Shigeru N,Seiji O,et al.Chronological changes of the contractile mechanism in prolonged vasospasm after subarachnoid hemorrhage:from protein kinase C to protein tyrosine kinase[J].Neurosurgery,2002,51(6):1468-1476.
  • 7Kusaka G,Kimura H,Kusaka I,et al.Contribution of Src tyrosine kinase to cerebral vasospasm after subarachnoid hemorrhage[J].J Neurosurg,2003,99:383-390.
  • 8周任,吕健,黄卫东,师蔚.创伤性脑血管痉挛与内皮素-1水平变化的关系[J].西安医科大学学报,2002,23(2):164-166. 被引量:8

二级参考文献9

  • 1Weber M,Grolimund P,Seiler RW,et al.Evaluation of posttraumatic cerebral blood flow velocities by transcranial Doppler ultrasonograph [J].Neurosurgery,1990,27(1):106-112.
  • 2Zimmermmann M,Seifert V.Endothelin and subarach-noidal hemorrage: an overview [J].Neurosurgery,1998,43(4):863-876.
  • 3Pluta RM,Boock RJ,Afshar JK,et al.Source and cause of endothelin-1 release into cerebrospinal fluid after sub-arachnoid hemorrhage [J].J Neurosurg,1997,87(2):287-293.
  • 4Pluta RM,Afshar JK,Thompson BG,et al.Increased cerebral blood flow but no reversal or prevention of vaso-spasm in response to L-arginine infusion after subarachnoid hemorrhage [J].J Neurosurg,2000,92(1):121-126.
  • 5Mima T,Yanagisaws M,Shigeno T,et al.Endothelin acts in feline and canine cerebral arteries from the adventitial side [J].Stroke,1989,20(11):1553-1556.
  • 6Roux S,Loftler BM.,Gray GA,et al.The role of endothelin in experimental cerebral vasospasm [J].Neurosurgery,1995,37(1):78-86.
  • 7Suzuki K,Mgeuro K,Sakurai T,et al.Endothelin-1 concentration increase in the cerebrospinal fluind in cerebral vasospasm caused by subarachnoid hemorrhage [J].Surg Neurol,2000,53(2):131-135.
  • 8Juvela S.Plasma endothelin concentrations after aneurysmalsubarachnoid hemorrhage [J].J Neurosurg,2000,92(3):390-400.
  • 9郭沂涟,李义召,刘爱芬,孙琳,迟兆富.蛛网膜下腔出血患者内皮素测定的临床意义[J].山东医科大学学报,2001,39(2):134-135. 被引量:6

共引文献7

同被引文献18

  • 1杨晓芬,武江,吕东方.蛛网膜下腔出血后迟发性脑血管痉挛的发病机制及治疗[J].河北医药,2006,28(10):978-980. 被引量:5
  • 2黄琳,李琴,王维亭,陈蔚江,郭莲军.盐酸法舒地尔对血管舒缩功能的调节作用[J].中国药理学通报,2007,23(2):251-256. 被引量:26
  • 3魏贤文,谢应翠,李冬雪,徐大斌,郭莺,鲁文莉.蛛网膜下腔出血后脑血管痉挛的早期处治与预后[J].罕少疾病杂志,2007,14(3):47-49. 被引量:1
  • 4Zhao J, Zhou D, Guo J, et al. Effect of fasudil hydrochloride, a protein ki- nase inhibitor, on cerebral vasospasm and delayed cerebral ischemie symp- toms after aneurysmar subaraehnoid hemorrbage[J]. Neurol Med Chir (Tokyo), 2006,46 (9) : 421 - 428.
  • 5Suzuki Y, Shibuya M, Satoh S, et al. A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnold hemorrhage[J]. Surg Neurol, 2007,68 (2) : 126 - 131.
  • 6Enomoto Y, Yoshimura S, Yamada K, et al. Convulsion during intra - arte- rial infusion of fasudil hydroehloride for the treatment of cerebral va- sospasm following subaraehnoid hemorrhage[J] .Neurol Med Chir (Tokyo),2010,50(1): 7 - 11.
  • 7Suzuki Y, Shibuya M, Satoh S, et al. Safety and efficacy of fasudil monotherapy and fasudil- ozagrel combination therapy in patients with subarachnoid hemorrhage: sub -analysis of the post- marketing surveil- lance study [ J ]. Neurol Med Chir (Tokyo), 2008,48 (6) : 241 - 347.
  • 8Hartshorne D J, Mrwa U. Regulation of smooth muscle actomyosin [ J ]. Blood Vessels, 1982,19 ( 1 ) : 1 - 18.
  • 9缪家培.钙离子进入细胞浆的途径与血管平滑肌收缩机制[J].生物科学进展,1989,20(1):49-52.
  • 10Takanashi Y, Ishida T, Meguro T, et al. Efficacy of intrathecal liposomal fasudil for experimental cerebral vasospasm after snbarachnoid hemor- rhage [ J ]. Neurosurgery, 2001,48 (4) : 894 - 900.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部